Want to see GB:SYNC full AI Analyst Report?
SYNC Stock Chart & Stats
107.00 p
-0.80 p(-0.74%)
At close: 4:00 PM EDT
107.00 p
-0.80 p(-0.74%)
Day’s Range― - ―
52-Week Range86.80 p - 131.80 p
Previous CloseN/A
Volume190.55K
Average Volume (3M)2.10M
Market Cap
£779.70M
Enterprise Value536.33M
Total Cash (Recent Filing)£1.92M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.01%
Share Statistics
EPS (TTM)-0.01
Shares Outstanding608,193,050
10 Day Avg. Volume290,612
30 Day Avg. Volume2,103,611
Financial Highlights & Ratios
PEG Ratio0.65
Price to Book (P/B)0.52
Price to Sales (P/S)9.39
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£189.00Price Target Upside76.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£49.14M
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetA debt-free structure materially reduces financial risk and avoids interest burdens or refinancing pressure. The substantial equity base provides resilience through volatile biotechnology markets and preserves flexibility to support portfolio companies or fund new investments over the next several quarters.
Recent Operating Cash FlowPositive operating cash flow in the three most recent annual periods indicates that the business has recently generated cash from its ongoing activities despite reported earnings volatility. This supports funding capacity and reduces reliance on external financing, even though consistency remains imperfect.
Long-term Life Sciences PlatformA focused life sciences investment model gives Syncona exposure to healthcare innovation while allowing it to provide patient capital and strategic support through development cycles. That model can create durable value if portfolio companies achieve clinical, regulatory or commercial milestones.
Bears Say
Persistent Loss-making PerformanceThe shift from profit to consecutive annual losses weakens earnings visibility and indicates that the existing capital base is not consistently producing positive returns. Continued losses could limit reinvestment capacity and make future results more dependent on portfolio valuation changes or successful exits.
Declining Revenue TrendA renewed revenue decline after an earlier recovery points to inconsistent operating momentum and reduces confidence in near-term earnings progression. For an investment company whose results depend heavily on portfolio outcomes, weaker revenue can reflect less reliable realisation activity or portfolio value generation.
Weakening Free Cash FlowFree cash flow falling to zero in the latest year reduces the quality and flexibility of financial performance, even with positive recent operating cash flow. The broader history of inconsistent cash generation may constrain funding for new investments and increase reliance on successful portfolio realisations.
Syncona Shs GBP News
SYNC FAQ
What was Syncona Shs GBP ’s price range in the past 12 months?
Syncona Shs GBP lowest share price was 86.80 p and its highest was 131.80 p in the past 12 months.
What is Syncona Shs GBP ’s market cap?
Syncona Shs GBP ’s market cap is £779.70M.
When is Syncona Shs GBP ’s upcoming earnings report date?
Syncona Shs GBP ’s upcoming earnings report date is Nov 12, 2026 which is in 20 days.
How were Syncona Shs GBP ’s earnings last quarter?
Syncona Shs GBP released its earnings results on Jun 18, 2026. The company reported 0.027 p earnings per share for the quarter.
Is Syncona Shs GBP overvalued?
According to Wall Street analysts Syncona Shs GBP ’s price is currently Undervalued.
Does Syncona Shs GBP pay dividends?
Syncona Shs GBP pays a Annually dividend of 2.3 p which represents an annual dividend yield of 1.01%. See more information on Syncona Shs GBP dividends here
What is Syncona Shs GBP ’s EPS estimate?
Syncona Shs GBP ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syncona Shs GBP have?
Syncona Shs GBP has 608,193,050 shares outstanding.
What happened to Syncona Shs GBP ’s price movement after its last earnings report?
Syncona Shs GBP reported an EPS of 0.027 p in its last earnings report. Following the earnings report the stock price went up 2.99%.
Which hedge fund is a major shareholder of Syncona Shs GBP ?
Currently, no hedge funds are holding shares in GB:SYNC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Syncona Shs GBP Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.84%
12-Months-Change
Fundamentals
Return on Equity
-0.86%
Trailing 12-Months
Asset Growth
-1.14%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Syncona Shs GBP
Syncona Ltd. is a closed-end investment fund, which engages in delivering returns from investments in long and alternative investment funds across multiple asset classes and targets. Its portfolio includes commercial companies, late-stage clinical companies, clinical companies, and pre-clinical companies. The company was founded on August 14, 2012 and is headquartered in St. Peter Port, the United Kingdom.
SYNC Stock 12 Month Forecast
Average Price Target
189.00 p
▲(76.64% Upside)
Technical Analysis
Ashmore Group PLC
―
Molten Ventures
―
IP Group plc
―
Mercia Asset Management
―
Caledonia Investments
―







